Source comparison
Best PT-141 Dosage for Erectile Function: Comparison Table
0.75mg +2.1 points vs baseline 12% 8% Subtherapeutic for most users. Useful as starting dose for tolerance assessment only 1.25mg +3.4 points vs baseline 22% 14% Clinically meaningful response in 50–60% of users. Valid maintenance dose for nausea-sensitive ind
This comparison does not assign a generated winner or score.
- 0.75mg
- +2.1 points vs baseline
- 12%
- 8%
- Subtherapeutic for most users. Useful as starting dose for tolerance assessment only
- 1.25mg
- +3.4 points vs baseline
- 22%
- 14%
- Clinically meaningful response in 50–60% of users. Valid maintenance dose for nausea-sensitive individuals
- 1.75mg
- +4.2 points vs baseline
- 31%
- 18%
- Optimal balance of efficacy and tolerability. This is the evidence-based target dose for erectile function
- 2.0mg
- +4.3 points vs baseline
- 54%
- 37%
- Marginal efficacy gain does not justify doubled nausea rate. Avoid unless 1.75mg definitively ineffective after 3+ trials
- 2.5mg+
- No additional benefit vs 1.75mg
- 68%+
- 45%+
- Clinically unjustified. Side effect rates exceed therapeutic value in all published trials